New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Grenoble
About this trial
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being a trans masculine individual
Taking a gender affirming hormonal therapy (GAHT)
living close to Grenoble
having pelvic pain that appeared or were modified after taking GAHT
Disqualifiers
Subject under guardianship or subject deprived of liberty Refusal of voice recording
Trial population
Trans masculine individuals using a gender affirming hormonal therapy (testosterone) and having pelvic pain.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Pelvic pain and impact on quality of life description
Verbatim from the semi structured interviews
Time frame
1.5 hours during semi structured interviewsSecondary outcomes
1
pelvic pain intensity at the time of the interview
visual analog scale from 0 to 100 mm
Time frame
at the beginning of the interviewSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov